Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
LKT/IDEBENONE/I1418/10 mg188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

LKT/IDEBENONE/I1418/10 mg

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References

Description

Idebenone is a synthetic quinone coenzyme Q (CoQ) analog that promotes mitochondrial respiration, increases ATP production, and inhibits lipoperoxide formation. Idebenone exhibits antioxidative, neuroprotective, cognition enhancing, cardioprotective, anti-inflammatory, and anti-fibrotic activities. In subjects with Alzheimer’s disease and in animal models of scopolamine-induced memory deficit, idebenone improves cognitive function and daily living aspects. Additionally, idebenone improves neurological function in subjects with Friedreich’s ataxia. In animal models of Duchennes Muscular Dystrophy (DMD), idebenone decreases cardiac inflammation and fibrosis and improves cardiac diastolic function and exercise performance.

Product Info

Cas No.

58186-27-9

Purity

≥98%

Formula

C18H28O5

Formula Wt.

324.41

Chemical Name

2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-benzoquinone

IUPAC Name

2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

Synonym

Avan; Daruma; Mnesis

Melting Point

46-50°C

Solubility

Soluble in organic solvents. Practically insoluble in water.

Appearance

Yellow-orange crystalline powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

Info Sheet

I1418 Info Sheet PDF

References

Buyse GM, Van der Mieren G, Erb M, et al. Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. Eur Heart J. 2009 Jan;30(1):116-24. PMID: 18784063.

Di Prospero NA, Baker A, Jeffries N, et al. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol. 2007 Oct;6(10):878-86. PMID: 17826341.

Gutzmann H, Kühl KP, Hadler D, et al. Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study. Pharmacopsychiatry. 2002 Jan;35(1):12-8. PMID: 11819153.

Liu XJ, Wu WT. Effects of ligustrazine, tanshinone II A, ubiquinone, and idebenone on mouse water maze performance. Zhongguo Yao Li Xue Bao. 1999 Nov;20(11):987-90. PMID: 11270979.

Suno M, Nagaoka A. Effect of idebenone and various nootropic drugs on lipid peroxidation in rat brain homogenate in the presence of succinate. Nihon Yakurigaku Zasshi. 1988 May;91(5):295-9. PMID: 3410376.

新闻动态
行业前沿
技术文章
最新产品